|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Avalo Therapeutics, Inc (AVTX) |
|
|
$0.43 0.00 (0.00%) as of 4:30 Thu 7/7
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
112,320,000 |
| Market
Cap: |
48.31(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4301 - $0.4301 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
79,351 |
662,763 |
| Total Buy Value |
$0 |
$0 |
$272,578 |
$643,635 |
| Total People Bought |
0 |
0 |
3 |
4 |
| Total Buy Transactions |
0 |
0 |
18 |
32 |
| Total Shares Sold |
0 |
0 |
5,291,542 |
5,291,542 |
| Total Sell Value |
$0 |
$0 |
$3,199,077 |
$3,199,077 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
4 |
4 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Harrell James Archie Jr |
Chief Commercial Officer |
• – – |
2020-06-10 |
4 |
B |
$2.28 |
$14,559 |
D/D |
6,391 |
28,009 |
2.74 |
-14% |
|
| Neil Garry Arthur |
Chief Scientific Officer |
• – – |
2020-06-10 |
4 |
B |
$2.28 |
$4,098 |
D/D |
1,799 |
74,081 |
2.66 |
-14% |
|
| Sullivan Christopher Ryan |
Interim CFO |
• – – |
2020-06-10 |
4 |
B |
$2.28 |
$6,729 |
D/D |
2,954 |
2,954 |
2.74 |
-14% |
|
| Boyd Steven |
Director |
– • • |
2020-06-09 |
4 |
B |
$0.00 |
$674,871 |
I/I |
267,806 |
1,100,000 |
2.25 |
-16% |
|
| Boyd Steven |
Director |
– • • |
2020-06-09 |
4 |
B |
$2.50 |
$4,384,200 |
D/D |
1,753,680 |
29,914,285 |
3.92 |
-16% |
|
| Harrell James Archie Jr |
Chief Commercial Officer |
• – – |
2020-06-09 |
4 |
B |
$2.50 |
$25,000 |
D/D |
10,000 |
21,618 |
2.74 |
-16% |
|
| Cola Michael F |
Chief Executive Officer |
• • – |
2020-06-09 |
4 |
B |
$2.50 |
$250,000 |
D/D |
100,000 |
175,746 |
2.81 |
-16% |
|
| Miller Joseph M |
Director |
– • – |
2020-06-08 |
4 |
D |
$3.22 |
$14,400 |
D/D |
(4,472) |
40,582 |
|
- |
|
| Pedder Simon |
Executive Chairman of the Bd |
• • – |
2020-04-09 |
4 |
D |
$2.57 |
$53,716 |
D/D |
(20,901) |
241,833 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2020-04-03 |
4 |
B |
$2.16 |
$9,245 |
I/I |
4,280 |
832,194 |
2.17 |
18% |
|
| Boyd Steven |
Director |
– • • |
2020-03-31 |
4 |
B |
$2.33 |
$62,004 |
I/I |
26,611 |
827,914 |
2.25 |
10% |
|
| Boyd Steven |
Director |
– • • |
2020-03-30 |
4 |
B |
$2.35 |
$115,862 |
I/I |
49,303 |
801,303 |
2.25 |
9% |
|
| Boyd Steven |
Director |
– • • |
2020-03-27 |
4 |
B |
$2.43 |
$87,480 |
I/I |
36,000 |
752,000 |
2.25 |
10% |
|
| Boyd Steven |
Director |
– • • |
2020-03-23 |
4 |
B |
$2.52 |
$3,462 |
I/I |
1,374 |
716,000 |
2.17 |
-0% |
|
| Boyd Steven |
Director |
– • • |
2020-03-20 |
4 |
B |
$2.50 |
$24,065 |
I/I |
9,626 |
714,626 |
2.17 |
2% |
|
| Boyd Steven |
Director |
– • • |
2020-03-19 |
4 |
B |
$2.60 |
$4,074 |
I/I |
1,567 |
705,000 |
2.17 |
-3% |
|
| Boyd Steven |
Director |
– • • |
2020-03-18 |
4 |
B |
$1.91 |
$54,307 |
I/I |
28,433 |
703,433 |
2.25 |
35% |
|
| Boyd Steven |
Director |
– • • |
2020-03-17 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
28,160,605 |
2.17 |
32% |
|
| Boyd Steven |
Director |
– • • |
2020-03-17 |
4 |
B |
$2.05 |
$3,999,999 |
D/D |
1,951,219 |
28,160,605 |
3.92 |
32% |
|
| Boyd Steven |
Director |
– • • |
2020-03-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(0) |
26,621,828 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2020-03-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,455,129) |
26,209,386 |
|
- |
|
| Neil Garry Arthur |
Chief Medical Officer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
72,282 |
72,282 |
|
- |
|
| Cola Michael F |
Chief Executive Officer |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,746 |
75,746 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2020-02-03 |
4 |
B |
$0.00 |
$1,094,500 |
I/I |
275,000 |
675,000 |
2.25 |
-36% |
|
| Boyd Steven |
Director |
– • • |
2020-02-03 |
4 |
B |
$3.98 |
$3,905,502 |
D/D |
981,282 |
29,664,515 |
3.92 |
-36% |
|
440 Records found
|
|
Page 5 of 18 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
